Immedica Pharma AB, a leading global rare disease company, and Marinus Pharmaceuticals, Inc, a pharmaceutical company committed to improving the lives of patients with...
Exicure, Inc, has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. on December 24, 2024, aimed at the acquisition...
Frost & Sullivan researched the bioinformatics-based drug discovery and development industry, and based on its analysis results, recognized DNAnexus, provider of the leading enterprise platform...
Adicet Bio, a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, announced the appointment...
